Discovery & CDMO

Aurigene Discovery & CDMO is a wholly owned subsidiary of Dr. Reddy’s Laboratories. It was created in 2020 by merging all service businesses within Dr. Reddy’s to build a strong customer-centric organization. Thus, Aurigene is a young and nimble company with more than two decades of experience.

Aurigene partners with global pharmaceutical and biotech companies to advance their molecules from laboratory to market. Aurigene offers integrated API, intermediate, and formulation services that span key starting materials, advanced intermediates, and APIs to finished products such as oral solids, sterile products, nasal solutions, and more. Aurigene lives by its purpose to accelerate access to affordable and innovative medicines because Good Health Can’t Wait.

Aurigene’ s focus on scientific expertise, technology, innovation, and problem-solving—along with strong fundamentals in sustainability, compliance, and IP security—has made it a preferred partner for many large pharma and biotech companies. Aurigene believes in fostering and nurturing long-term partnerships through work built on speed, adaptability, clarity of communication, and collaboration.